Johnson & Johnson Merck, headquartered in Ft. Washington, Pennsylvania, issued a recall of PEPCID Complete and PECID AC tablets on Aug. 20, 2010, according to the U.S. Federal Drug Enforcement Agency. The recall affected several strengths and bottle counts.
The recall of PEPCID Complete tablets resulted from a defective container issue, notes the FDA. Inspectors found punctures in a small number of bottles, along the bottom edges. The punctures occurred during the packaging process. The recall affected 50-count bottles of PEPCID Complete tablets in 10-, 165- and 800-milligram doses. Also pulled during the recall were 90-count bottles of 10-milligram PEPCID AC tablets.